Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells
Xanthoxyletin is a vital plant-derived bioactive coumarin. It has been shown to exhibit anticancer effects against different human cancers. Nonetheless, the anticancer effects of xanthoxyletin against human pancreatic cancer cells have not been evaluated. Against this backdrop, the present study was...
Saved in:
| Main Authors: | Zhang Xin, Li Luming, Wu Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2023-09-01
|
| Series: | Acta Pharmaceutica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/acph-2023-0024 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brominated flame retardant BDE-99 promotes apoptosis by intrinsic mitochondrial pathway in rat liver
by: Elvan Bakar, et al.
Published: (2025-04-01) -
Targeted pancreatic cancer therapy using 4-farnesyloxycoumarin conjugated nanocrystalline cellulose and Chitosan nanoparticles
by: Fariba Karoonkiani, et al.
Published: (2025-05-01) -
The antineoplastic effects of nuciferine on hepatocellular carcinoma are associated with suppression of the HER2-AKT/ERK1/2 signaling pathway
by: Tiantian Li, et al.
Published: (2025-05-01) -
Sulforaphane Inhibits Pancreatic Cancer PANC-1 Cell Activity through Activation of the p53 Signaling Pathway
by: Ziyi REN, et al.
Published: (2025-09-01) -
The role of m6A methylation genes in predicting poor prognosis in sepsis: identifying key biomarkers and therapeutic targets
by: Shaokang Wang, et al.
Published: (2024-12-01)